as on October 25, 2025 at 1:29 am IST
Day's Low
Day's High
1.50%
Downside
2.20%
Upside
52 Week's Low
52 Week's High
34.22%
Downside
35.28%
Upside
Check Jade Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$280.1M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Jade Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $280.1M | NA | NA | 0.00% | |
| BUY | $60.9B | 251.51% | -505.15 | -12.96% | |
| NA | $35.7B | NA | NA | -3.89% | |
| BUY | $109.3B | 99.16% | 30.04 | 31.86% | |
| BUY | $62.0B | -0.32% | 14.51 | 31.37% |
Search interest for Jade Biosciences Inc Stock has increased by 183% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:183% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, JBIO stock has moved up by 24.1%
Best in 1 Year
![]()
In the last 1 year, JBIO has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 133.4% return, outperforming this stock by 185.8%
| Organisation | Jade Biosciences Inc |
| Headquarters | Building 23, Waltham, MA, United States, 02453 |
| CEO | Mr. Tom Frohlich |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Bradford D. Dahms Ph.D. | Chief Financial Officer |
Dr. Andrew James King D.V.M., Ph.D. | Chief Scientific Officer & Head of R&D |
Ms. Elizabeth Balta | General Counsel & Corporate Secretary |
Ms. Valerie Fauvelle | Senior Vice President of Regulatory & Quality |
Ms. Sandy Lewis | Senior Vice President, Biometrics & Clinical Strategy |
Mr. Tom Frohlich | CEO & Director |
Ms. Lori Stewart | Senior Vice President of People |
Dr. Jason Wright Ph.D. | Senior Vice President of Chemistry, Manufacturing & Controls |
Mr. Jonathan Quick | Senior Vice President of Finance |
Ms. Amy Sullivan | Senior Vice President of Development Operations |
Jade Biosciences Inc share price today is $9.98 as on at the close of the market. Jade Biosciences Inc share today touched a day high of $10.2 and a low of $9.83.
Jade Biosciences Inc share touched a 52 week high of $13.5 on and a 52 week low of $6.57 on . Jade Biosciences Inc stock price today i.e. is closed at $9.98,which is 26.08% down from its 52 week high and 52.02% up from its 52 week low.
Jade Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Jade Biosciences Inc (JBIO) shares with as little as ₹87.759 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.59 in Jade Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Jade Biosciences Inc share’s latest price of $9.98 as on October 25, 2025 at 1:29 am IST, you will get 1.0020 shares of Jade Biosciences Inc. Learn more about
fractional shares .